RecruitingNot ApplicableNCT07533903

Functional Outcomes and Control Using Synchron BCI - Australia

Functional Outcomes and Control Using Synchron BCI - Australia (FOCUS-AUS)

Sponsor

Synchron, Inc.

Enrollment

10 participants

Start Date

May 22, 2026

Study Type

INTERVENTIONAL

Conditions

Neurologic Disorder Motor Neuron Disease Motor Neuron Disease / Amyotrophic Lateral Sclerosis Paralysis Paralysis Arm MND (Motor Neurone DIsease)Neurologic Diseases

Summary

Functional Outcomes and Control Using Synchron BCI - Australia (FOCUS-AUS)

Eligibility

Min Age: 21 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Stentrode for people with mnd (motor neurone disease), motor neuron disease, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 21 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEStentrode

The Stentrode is an endovascular electrode array that senses electrical signals from the sensorimotor cortices.

Locations(1)

The Royal Melbourne Hospital

Melbourne, Australia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07533903

Related Trials

Electrical Impedance Myography: Natural History Studies inNeuromuscular Disorders and Healthy Volunteers

NCT019001321 location

Combined Whole-brain Structural and Functional MRI for the Prediction of Neurological Recovery After Cardiac Arrest

NCT066173771 location